HAILY HELTON: Open Payments
NPI 1063018141 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 31 payments from 10 companies in 2025. Trend: 2023 $333 · 2024 $688 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $154 |
| ABBVIE INC. | 8 | $146 |
| Novartis Pharmaceuticals Corporation | 6 | $140 |
| Novo Nordisk Inc | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Lilly USA, LLC | 1 | $25 |
| Exact Sciences Corporation | 1 | $23 |
| Exeltis, USA Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: JARDIANCE, LEQVIO, Wegovy, CREON, REXULTI, INVEGA SUSTENNA, BOTOX, MOUNJARO.
Industry payments across CA — which companies pay providers there.
